{"title":"鼻内/肌内和肌内接种脑膜炎球菌抗原后全身免疫的比较","authors":"A. Portilho, V. Correa, E. Gaspari","doi":"10.35259/isi.2022_52207","DOIUrl":null,"url":null,"abstract":"This study compared the systemic immune response to IN/intramuscular (IM) and IM/IM delivery of meningococcal outer membrane vesicles (OMVs). Methodology: A/Sn (H2 a ) mice were immunized with 4 subsequent IN doses (0.2 μg OMVs+0.1 μg Cholera toxin subunit B [CTB]) (Sigma-Aldrich) and one IM booster (0.2 μg OMVs+0.2 μg CTB) after 15 days. For comparison, another group received 2 IM doses, 15 days apart (0.2 μg OMVs+0.1 mM Aluminium hidroxyde [AH]). Control groups received only adjuvants. Antigen control received 2 IM doses (0.2 μg OMVs), 15 days apart. The humoral response was assessed by ELISA and serum bactericidal assay (SBA) and the cellular response, by ELISpot. Results: OMVs+CTB had increased IgG titers compared to pre-immune control after the IN doses (p<0.05) and, after booster, it increased even more (p<0.01). OMV+AH was superior to pre-immune (p<0.001) and AH (p<0.05) controls after 2 doses. OMVs alone did not elicit statistically higher titers, although it was higher than pre-immune sera. There was no significance in IgG2a titers, while IgG1 was increased in OMV+CTB and OMV+AH compared to controls (p<0.05 for all). OMVs alone were not bactericidal, while OMV+CTB and OMV+AH were (SBA titers 1/8 and 1/16, respectively). ELISpot was conducted when mice were elderly (after 475) to assess immunologic memory. IL-4 release after antigenic stimuli was higher in OMV+CTB and OMV+AH groups than in OMVs group. The immunization also induced IL-17 release, especially by the OMV+CTB group. Conclusion: Low antigenic doses of OMVs were immunogenic and induced immunologic memory. 4 IN doses were effective to induce systemic IgG. Adjuvants were needed to increase IgG titers and to guarantee bactericidal activity. AH and CTB modulated a Th2 response, with higher IgG1 titers and IL-4 secretion. The IN/IM approach was comparable to the IM/IM one to induce systemic immunity.","PeriodicalId":8089,"journal":{"name":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of systemic immunity following intranasal/intramuscular and intramuscular immunization with meningococci antigens\",\"authors\":\"A. Portilho, V. Correa, E. Gaspari\",\"doi\":\"10.35259/isi.2022_52207\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This study compared the systemic immune response to IN/intramuscular (IM) and IM/IM delivery of meningococcal outer membrane vesicles (OMVs). Methodology: A/Sn (H2 a ) mice were immunized with 4 subsequent IN doses (0.2 μg OMVs+0.1 μg Cholera toxin subunit B [CTB]) (Sigma-Aldrich) and one IM booster (0.2 μg OMVs+0.2 μg CTB) after 15 days. For comparison, another group received 2 IM doses, 15 days apart (0.2 μg OMVs+0.1 mM Aluminium hidroxyde [AH]). Control groups received only adjuvants. Antigen control received 2 IM doses (0.2 μg OMVs), 15 days apart. The humoral response was assessed by ELISA and serum bactericidal assay (SBA) and the cellular response, by ELISpot. Results: OMVs+CTB had increased IgG titers compared to pre-immune control after the IN doses (p<0.05) and, after booster, it increased even more (p<0.01). OMV+AH was superior to pre-immune (p<0.001) and AH (p<0.05) controls after 2 doses. OMVs alone did not elicit statistically higher titers, although it was higher than pre-immune sera. There was no significance in IgG2a titers, while IgG1 was increased in OMV+CTB and OMV+AH compared to controls (p<0.05 for all). OMVs alone were not bactericidal, while OMV+CTB and OMV+AH were (SBA titers 1/8 and 1/16, respectively). ELISpot was conducted when mice were elderly (after 475) to assess immunologic memory. IL-4 release after antigenic stimuli was higher in OMV+CTB and OMV+AH groups than in OMVs group. The immunization also induced IL-17 release, especially by the OMV+CTB group. Conclusion: Low antigenic doses of OMVs were immunogenic and induced immunologic memory. 4 IN doses were effective to induce systemic IgG. Adjuvants were needed to increase IgG titers and to guarantee bactericidal activity. AH and CTB modulated a Th2 response, with higher IgG1 titers and IL-4 secretion. The IN/IM approach was comparable to the IM/IM one to induce systemic immunity.\",\"PeriodicalId\":8089,\"journal\":{\"name\":\"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes\",\"volume\":\"40 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35259/isi.2022_52207\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the symposium: vaccines, biopharmaceuticals, in vitro diagnosis, management, other related themes","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35259/isi.2022_52207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Comparison of systemic immunity following intranasal/intramuscular and intramuscular immunization with meningococci antigens
This study compared the systemic immune response to IN/intramuscular (IM) and IM/IM delivery of meningococcal outer membrane vesicles (OMVs). Methodology: A/Sn (H2 a ) mice were immunized with 4 subsequent IN doses (0.2 μg OMVs+0.1 μg Cholera toxin subunit B [CTB]) (Sigma-Aldrich) and one IM booster (0.2 μg OMVs+0.2 μg CTB) after 15 days. For comparison, another group received 2 IM doses, 15 days apart (0.2 μg OMVs+0.1 mM Aluminium hidroxyde [AH]). Control groups received only adjuvants. Antigen control received 2 IM doses (0.2 μg OMVs), 15 days apart. The humoral response was assessed by ELISA and serum bactericidal assay (SBA) and the cellular response, by ELISpot. Results: OMVs+CTB had increased IgG titers compared to pre-immune control after the IN doses (p<0.05) and, after booster, it increased even more (p<0.01). OMV+AH was superior to pre-immune (p<0.001) and AH (p<0.05) controls after 2 doses. OMVs alone did not elicit statistically higher titers, although it was higher than pre-immune sera. There was no significance in IgG2a titers, while IgG1 was increased in OMV+CTB and OMV+AH compared to controls (p<0.05 for all). OMVs alone were not bactericidal, while OMV+CTB and OMV+AH were (SBA titers 1/8 and 1/16, respectively). ELISpot was conducted when mice were elderly (after 475) to assess immunologic memory. IL-4 release after antigenic stimuli was higher in OMV+CTB and OMV+AH groups than in OMVs group. The immunization also induced IL-17 release, especially by the OMV+CTB group. Conclusion: Low antigenic doses of OMVs were immunogenic and induced immunologic memory. 4 IN doses were effective to induce systemic IgG. Adjuvants were needed to increase IgG titers and to guarantee bactericidal activity. AH and CTB modulated a Th2 response, with higher IgG1 titers and IL-4 secretion. The IN/IM approach was comparable to the IM/IM one to induce systemic immunity.